Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Aug 31, 2024 | (FY)Aug 31, 2023 | (FY)Aug 31, 2022 | (FY)Aug 31, 2021 | (FY)Aug 31, 2020 | (FY)Aug 31, 2019 | (FY)Aug 31, 2018 | (FY)Aug 31, 2017 | |
---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||
Cash from operating activities | 5.78%3.71B | 246.75%3.51B | -1,049.28%-2.39B | -129.56%-208.12M | 8.45%703.99M | 98.94%649.15M | 184.93%326.3M | -384.18M |
Net profit before non-cash adjustment | 28.20%2.24B | 296.60%1.75B | -0.56%440.75M | -52.01%443.24M | 41.73%923.58M | 20.71%651.63M | 274.41%539.82M | --144.18M |
Total adjustment of non-cash items | 12.68%216.74M | 148.66%192.35M | -159.49%-395.32M | -97.41%-152.35M | -563.50%-77.17M | 92.84%-11.63M | -114.72%-162.34M | ---75.61M |
-Depreciation and amortization | 67.36%184.28M | 382.15%110.11M | -8.23%22.84M | 7.23%24.89M | -16.12%23.21M | 23.59%27.67M | 30.69%22.39M | --17.13M |
-Reversal of impairment losses recognized in profit and loss | --157.93M | --0 | ---- | --7.22M | ---- | 15.13%2.98M | -57.45%2.59M | --6.09M |
-Disposal profit | --0 | 102.55%1.24M | ---48.54M | ---- | ---30M | --0 | 673.54%13.13M | ---2.29M |
-Other non-cash items | -254.89%-125.47M | 121.91%81M | -100.39%-369.62M | -162.08%-184.45M | -66.46%-70.38M | 78.91%-42.28M | -107.65%-200.45M | ---96.54M |
Changes in working capital | -20.03%1.26B | 164.40%1.57B | -388.43%-2.44B | -250.38%-499.01M | -1,656.32%-142.42M | 117.88%9.15M | 88.70%-51.18M | ---452.75M |
-Change in receivables | -126.88%-322.86M | 150.75%1.2B | -255.95%-2.37B | -193.27%-664.98M | 6.88%-226.74M | 10.88%-243.5M | 66.48%-273.23M | ---815.13M |
-Change in inventory | 55.33%128.93M | 74.02%83M | 247.18%47.7M | -120.15%-32.41M | 220.31%160.82M | -32.68%50.21M | 138.21%74.58M | --31.31M |
-Change in payables | 199.73%1.32B | 86.80%440.51M | -16.02%235.82M | 784.45%280.8M | -130.99%-41.03M | -32.36%132.37M | -39.92%195.7M | --325.71M |
-Provision for loans, leases and other losses | -149.15%-14.26M | 6.16%29.01M | 1,769.33%27.33M | 74.85%-1.64M | -117.45%-6.51M | 240.43%37.29M | 1,015.58%10.96M | --982K |
-Changes in other current assets | 149.22%90.39M | 52.19%-183.64M | -367.25%-384.07M | -3,136.14%-82.2M | -81.04%-2.54M | 97.57%-1.4M | -212.44%-57.85M | --51.45M |
-Changes in other current liabilities | 13,020.34%52.72M | -114.09%-408K | 106.49%2.9M | 105.31%1.4M | -177.28%-26.42M | 2,672.23%34.19M | 97.18%-1.33M | ---47.07M |
Dividends paid (cash flow from operating activities) | ||||||||
Dividends received (cash flow from operating activities) | ||||||||
Interest paid (cash flow from operating activities) | 20.11%-9.21M | -62.04%-11.53M | -6.40%-7.12M | 32.11%-6.69M | 3.75%-9.85M | 0.88%-10.24M | -1.10%-10.33M | -10.21M |
Interest received (cash flow from operating activities) | -11.77%2.06M | 39.38%2.34M | -51.88%1.68M | 26.15%3.48M | 14.23%2.76M | -41.91%2.42M | 12.01%4.16M | 3.72M |
Tax refund paid | -351.84%-806.82M | -28.08%-178.56M | 40.63%-139.41M | 21.89%-234.81M | -821.68%-300.62M | -81.22%-32.62M | -32.95%-18M | -13.54M |
Other operating cash inflow (outflow) | 0 | -1K | 0 | 0 | 0 | 132.44M | 0 | -1K |
Operating cash flow | -12.74%2.9B | 230.97%3.32B | -468.60%-2.54B | -212.58%-446.13M | -46.53%396.28M | 145.31%741.16M | 174.75%302.14M | ---404.21M |
Investing cash flow | ||||||||
Net PPE purchase and sale | -18.54%-32.61M | -119.12%-27.51M | 698.27%143.85M | -356.50%-24.04M | 80.87%-5.27M | 66.93%-27.54M | -310.71%-83.27M | ---20.28M |
Net intangibles purchase and sale | 66.23%-209.71M | -25,516.83%-620.95M | 60.76%-2.42M | 43.69%-6.18M | -3,393.63%-10.97M | ---314K | ---- | ---- |
Net business purchase and sale | ---43.76M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | -100.18%-4K | 55,825.00%2.23M | 80.95%-4K | -100.07%-21K | 142,857.14%29.98M | -100.06%-21K | -41.08%37.49M | --63.63M |
Net changes in other investments | -425.28%-83.38M | -521.78%-15.87M | 60.99%-2.55M | -15.03%-6.55M | -127.29%-5.69M | 120.70%20.85M | -8,263.37%-100.74M | --1.23M |
Investing cash flow | 44.20%-369.47M | -576.79%-662.11M | 477.49%138.87M | -556.87%-36.79M | 214.64%8.05M | 95.21%-7.02M | -428.60%-146.52M | --44.59M |
Financing cash flow | ||||||||
Net issuance payments of debt | -202.56%-205.12M | -81.82%200M | 466.67%1.1B | -200.00%-300M | 0.00%-100M | ---100M | ---- | --200M |
Net common stock issuance | -91.11%2.84M | --31.95M | --0 | -97.07%4.98M | -81.17%169.73M | --901.19M | ---- | ---- |
Cash dividends paid | -9.81%-96.71M | -9.11%-88.07M | -10.35%-80.71M | ---73.14M | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | 100.57%1K | -109.01%-175K | 2,384.71%1.94M | 99.69%-85K | -63.94%-27.53M | ---16.79M | ---- | ---- |
Financing cash flow | -308.05%-298.98M | -85.93%143.71M | 377.32%1.02B | -972.55%-368.25M | -94.62%42.2M | --784.4M | ---- | --200M |
Net cash flow | ||||||||
Beginning cash position | 217.52%4.09B | -51.64%1.29B | -24.20%2.67B | 14.54%3.52B | 97.86%3.07B | 11.15%1.55B | -10.26%1.4B | --1.56B |
Current changes in cash | -20.45%2.23B | 303.68%2.8B | -61.73%-1.38B | -290.62%-851.17M | -70.59%446.54M | 875.83%1.52B | 197.49%155.62M | ---159.62M |
Cash adjustments other than cash changes | ---- | --1K | ---- | -200.00%-2K | --2K | ---- | -200.00%-1K | --1K |
End cash Position | 54.50%6.32B | 217.52%4.09B | -51.64%1.29B | -24.20%2.67B | 14.54%3.52B | 97.86%3.07B | 11.15%1.55B | --1.4B |
Free cash flow | -0.65%2.66B | 204.33%2.67B | -438.02%-2.56B | -225.34%-476.36M | -46.72%380.04M | 238.46%713.31M | 149.65%210.76M | ---424.49M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |